Life Sciences

The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in ...

This study explores Western Europes dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical dia...

This research service provides an in-depth analysis of the advanced visualisation solutions market in Western Europe. It analyses the revenue potential, market dynamics, and trends across several countries in the region. Revenues for the advanced visualisation solutions market have been derived after studying the dynamics of different market segmen...

This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...

This issue of Vital Signs, released on October 3, 2014, discusses Merck KGaAs acquisition of Sigma-Aldrich, highlights from the 2014 AACC Meeting, Abbotts CE Mark for FreeStyle® Libre, laboratory developed test (LDT) regulations, and the sale of Fortis Healthcares Singapore subsidiary, RadLink-Asia Pte Ltd, and its arm, RadLink Singapore.

The increasing life science research activities across drug discovery applications have driven the need for automated products in liquid handling. How far the automated segments are going to replace the manual instruments is analyzed in this research. This study provides the market overview, market engineering measurements, revenue forecasts, compa...

This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.

This research service provides an in-depth analysis of the European breast imaging systems market. It analyses the revenue potential, market dynamics, and trends across countries in Western Europe. Market revenues have been derived from studying the dynamics of different segments which include: X-ray mammography, breast ultrasound, breast magnetic...